Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
In this month’s update, Dr. Tracy Pfeifer highlights all the doctors who volunteer to help surgeons reach their goals, being up to date on cybersecurity, and the upcoming The MEET 2026 in Boston!
It is just about two months from The Aesthetic MEET, and we have no lack of education, networking, and fun for you to take part in while you are in Boston. There are many opportunities to engage with and support The Aesthetic Foundation during The MEET, and I look forward to connecting and sharing all that has been accomplished with you.
In this study, 11 patients were injected with Volbella XC into the tear trough region and subsequently underwent undereye volumetric measurements over a 90-day period.
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”